 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
ADOLOR CORP, (ADLR) Stock Rating Learn More
| Our Overall Rating on ADOLOR CORP, ADLR is Not Available | | Adolor Corporation, a development stage biopharmaceutical corporation, engages in the discovery, development, and commercialization of prescription pain management products primarily in the United States. It offers Entereg (alvimopan) that is designed to block the unwanted effects of opioid analgesics on the gastrointestinal tract. The company also provides sterile lidocaine patch, which is in preclinical development, to treat postoperative incisional pain; analgesics for treating moderate-to-severe pain conditions. The company is collaborating with Glaxo for the development and commercialization of Entereg in multiple indications; and with EpiCept Corporation to develop and commercialize a sterile lidocaine patch in North America. Adolor was formed in 1993 and is based in Exton, Pennsylvania. | | Our Not Available Rating on ADLR was issued on 11/19/2008 |
ADOLOR CORP Technical Rating
|
|
|
|
